HOOKIPA Pharma (NASDAQ:HOOK) Stock, Quote.Headers.trade-ideas

HOOKIPA Pharma

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Biotech

Earnings

Earnings Misses

News

Penny Stocks

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

GBIO

HOOK

Generation Bio Co. (NASDAQ: GBIO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.

Generation Bio Co. Reports Q2 Loss, Tops Revenue Estimates

HOOKIPA Pharma shares are trading lower by 10.9% during Monday&#39;s session. The company announced a 1-for-10 reverse stock split.

Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today

xr:d:DAFq124ixJ4:2,j:8965939907255816403,t:23080707

Price Target

CRWD

RLMD

SITE

Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

HOOKIPA Pharma Inc

Hooker Furnishings Corporation - Common Stock

Hooker Furnishings Corp

American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) has outperformed the market over the past 5 years by 6.7% on an annualized basis producing an average annual return of 19.32%. Currently, American Express has a market capitalization of $210.23 billion. 
Buying $1000 In AXP: If an investor had bought $1000 of AXP stock 5 years ago, it would be worth $2,405.53 today based on a price of $298.43 for AXP at the time of writing.
<h3>American Express's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735861508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Ryan Reynolds, the guy most people know as Deadpool, has quietly been building an empire worth talking about. While his comedic timing and charm have made him a Hollywood darling, his business moves might be even more impressive.&nbsp;
Forbes recently reported that the companies he's co-owned or sold are valued at a <a href="https://www.benzinga.com/general/24/01/36875491/ryan-reynolds-co-owned-or-sold-companies-are-valued-at-14-billion-but-he-says-thank-god-i-am-not-run">jaw-dropping $14 billion</a>. That's right – billion with a B. And yet, when asked about his role in these ventures, Reynolds casually quipped, "Thank God I am not running the company." Humble much?+
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
The man's portfolio is as eclectic as it gets: an F1 team, a football club (the other kind of football), a gin brand, a wireless provider and even an advertising agency. It's not just about slapping his name on a product either. Reynolds has mastered the art of turning everyday businesses into cultural phenomena, often using his signature wit and relatability to make it happen.
Take Aviation American Gin, for example. When Reynolds bought a stake, he didn't just throw money at it – he became the face and voice of the brand. His tongue-in-cheek marketing campaigns helped skyrocket its popularity, ultimately leading to its $610 million sale to Diageo in 2020. That's not a win; that's a master class in branding.
Then there's Mint Mobile. Under Reynolds' watchful eye (and cheeky commercials), the wireless provider went from a scrappy underdog to a billion-dollar success story. When T-Mobile acquired it for <a href="https://www.benzinga.com/startups/24/08/40105515/ryan-reynolds-sold-2-companies-for-2-billion-now-hes-investing-in-clothing-cant-be-good-at-something">$1.35 billion in 2023,</a> Reynolds stayed on as a spokesperson because he knows a good gig when he sees one.
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
But Reynolds isn't pretending to be some business genius. In fact, he's refreshingly candid about how much he doesn't know. When discussing his investment in fintech company Nuvei Corp. on Squawk Box, he admitted, "I know nothing about fintech," adding with a laugh, "Thank God I am not running the company." Instead, he leans on strong teams and "emotional investing." Translation: He bets on brands with good stories to tell and the potential to resonate with consumers personally.
As Reynolds explained, "How does this happen if you look at a gin company, a wireless company and a Welsh football club? They don't go together, but they all had strong brand foundations." He has a knack for spotting opportunities where others might not, turning those opportunities into authentic, memorable narratives.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
In an August 2018 interview on The Tonight Show, Jimmy Fallon asked Ryan Reynolds how he got involved with Aviation Gin. With his trademark humor, Reynolds explained, "It's an American gin. Little smoother than our British counterparts, little pro-drinkable." Then, catching himself, he joked, "Uh, wow, I sound like a pro." Fallon laughed and agreed, prompting Reynolds to add, "I know nothing about gin. If I ran the company for real, it'd be on fire."
This mix of <a href="https://www.benzinga.com/startups/24/05/38811005/ryan-reynolds-sold-mint-mobile-for-1-35-billion-now-hes-invested-in-the-apparel-company-for-travis-k">intuition, humor and strategic marketing</a> makes his approach unique. It's also fueling his climb toward billionaire status – not bad for a guy who still jokes about being clueless half the time. Whether or not he officially joins the billionaire club soon, one thing's clear: Ryan Reynolds isn't just playing the game; he's rewriting the rules.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Ryan Reynolds Sold 2 Companies For $2 Billion In Just 4 Years But Says He's Not An Expert – 'If I Ran The Company For Real, It'd Be On Fire'

Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) has outperformed the market over the past 5 years by 11.3% on an annualized basis producing an average annual return of 23.91%. Currently, Ensign Group has a market capitalization of $7.61 billion. 
Buying $1000 In ENSG: If an investor had bought $1000 of ENSG stock 5 years ago, it would be worth $2,905.53 today based on a price of $132.87 for ENSG at the time of writing.
<h3>Ensign Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735860609_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ENSG

Here's How Much $1000 Invested In Ensign Group 5 Years Ago Would Be Worth Today

A battle between Elon Musk and Sam Altman over the new course of OpenAI was one of the bigger stories for 2024 in the <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence sector.</a>
With the case far from closed, the well-known "Godfather of AI" Geoffrey Hinton is weighing in and taking sides.
What Happened: A <a href="https://www.benzinga.com/24/11/42022920/sam-altman-slams-elon-musks-left-wing-bias-claims-over-chatgpt-responds-to-grok-vs-gpt-debate-with-bold-remarks-but-tesla-ceo-says-swindly-sam-is-at-it-again">push by OpenAI </a>to turn into a for-profit structure from a current nonprofit has prompted a legal attempt by Musk to block the change.
Musk, who is an original co-founder and investor in OpenAI, has spoken out about the planned for-profit change and is now gaining support from one of the biggest names in the AI sector.
"OpenAI was founded as an explicitly safety-focused nonprofit and made a variety of safety-related promises in its charter," Hinton said in a statement Monday published by youth-led advocacy group <a href="https://encodeai.org/encode-backs-legal-challenge-to-openais-for-profit-switch/">Encode</a>.
Hinton said OpenAI received benefits like tax breaks thanks to its nonprofit status.
"Allowing it to tear all of that up when it becomes inconvenient sends a very bad message to other actors in the ecosystem," Hinton said, as <a href="https://nypost.com/2024/12/31/business/geoffrey-hinton-backs-elon-musks-legal-battle-against-openai/">reported </a>by the New York Post.
Hinton, who won the <a href="https://www.benzinga.com/news/24/10/41233245/ai-godfather-geoffrey-hinton-wins-nobel-prize-for-artificial-intelligence-work-work-has-already-been">2024 Nobel Prize</a> in October, has spoken out against OpenAI in the past.
In October, Hinton said Altman is "much less concerned with safety than with profits." Hinton has also expressed regrets for his role in helping develop AI, which could now be used for negative items.
You may not be a billionaire like Mark Cuban, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/general/social-media/24/12/42490690/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five stocks flying under the radar that deserve your attention.</a>
Why It's Important: Founded in 2015 as a nonprofit research lab, OpenAI has become one of the largest companies by valuation in the space. The company created a capped-profit model in 2019 with the nonprofit holding control of the entire company.
The company has said that switching to a for-profit model will help "to raise the necessary capital with conventional terms like others in the space."
The lawsuit by Musk comes as he cut his relationship with OpenAI in 2018 and his lawsuit attempts come as he recently launched his own AI company xAI, a competitor to the company he co-founded.
Musk said that OpenAI executives "deceived" him in the past. OpenAI countered recently by saying Musk wanted a for-profit structure for the company in 2017.
The billionaire's lawsuit was first filed in early 2023 related to OpenAI's partnership with Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), which he alleged broke the company's nonprofit commitment.
Altman <a href="https://www.benzinga.com/24/12/42609769/elon-musk-is-a-legendary-entrepreneur-but-also-a-bully-says-openai-ceo-sam-altman-now-its-me-its-been-bezos-gates-zuckerberg-lots-of-other-people">recently showed appreciation</a> for what Musk did to help support OpenAI "in the early days," but shared new criticism of the billionaire.
"He's also clearly a bully and he's also someone who clearly likes to get in fights. Now it's me, it's been Bezos, Gates, Zuckerberg lots of other people," Altman said.
In the battle against OpenAI, Musk has now gained recent support from Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and the &#8220;Godfather of AI,&#8221; which could make the fight against Altman and OpenAI a must-watch story in 2025.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/06/39319028/terminator-in-real-life-ai-godfather-warns-of-human-wipe-out-in-5-to-20-years">Terminator In Real Life? AI &#8216;Godfather&#8217; Warns Of Human &#8216;Wipe Out&#8217; In 5 To 20 Years</a></li>
</ul>
Photo: DIA TV via Shutterstock

Education

Tech

MSFT

Elon Musk Gets Support From 'Godfather Of AI' Geoffrey Hinton In Battle Against OpenAI

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) has outperformed the market over the past 10 years by 4.09% on an annualized basis producing an average annual return of 15.28%. Currently, Novo Nordisk has a market capitalization of $389.06 billion. 
Buying $1000 In NVO: If an investor had bought $1000 of NVO stock 10 years ago, it would be worth $4,177.57 today based on a price of $87.60 for NVO at the time of writing.
<h3>Novo Nordisk's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735859706_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today

Ault &amp; Company has the right to purchase up to $25 million in shares of Hyperscale Data's Series G Convertible Preferred Stock in compliance with the federal securities laws.
Ault &amp; Company continues to believe that the current stock price of the Common Stock is below Hyperdrive Data's long-term intrinsic value per share and believes that an investment in the Preferred Shares demonstrates the continued commitment of Ault &amp; Company to supporting Hyperscale Data and its stockholders.

GPUS

Reported Earlier, Ault Reveals Abandonment Of Dutch Tender Offer To Acquire Common Shares Of Hyperscale Data

Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) has outperformed the market over the past 20 years by 3.76% on an annualized basis producing an average annual return of 12.08%. Currently, Norfolk Southern has a market capitalization of $53.08 billion. 
Buying $100 In NSC: If an investor had bought $100 of NSC stock 20 years ago, it would be worth $969.69 today based on a price of $234.60 for NSC at the time of writing.
<h3>Norfolk Southern's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735858810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

On December 31, 2024, the Board of Directors of Annaly Capital authorized a new common share repurchase program and a new preferred share repurchase program, each of which shall expire on December 31, 2029.

Buybacks

Annaly Capital Management Plans Repurchase Of Up To $1.5B Of Its Outstanding Shares Of Common Stock - Filing

Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) has outperformed the market over the past 5 years by 26.11% on an annualized basis producing an average annual return of 38.72%. Currently, Fair Isaac has a market capitalization of $48.94 billion. 
Buying $100 In FICO: If an investor had bought $100 of FICO stock 5 years ago, it would be worth $519.77 today based on a price of $1995.92 for FICO at the time of writing.
<h3>Fair Isaac's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735857908_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FICO

Here's How Much $100 Invested In Fair Isaac 5 Years Ago Would Be Worth Today

One of the more unusual trades by a member of Congress in 2024 was Rep. Mike Collins (R-Ga.) buying meme cryptocurrency Ski Mask Dog Coin (CRYPTO:SKI), which led to the crypto soaring in value and later hitting all-time highs shortly<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42330146/congressman-buys-meme-coins-ski-mask-dog-coin-climbs-in-value-after-disclosure-i-liked-the-coins-so-i-bought-them"> after the disclosure.</a>
A new filing shows Collins bought more after his last disclosure.
What Happened: The trading activity of <a href="https://www.benzinga.com/topic/congress-trading">members of Congress</a> continues to be closely followed by investors as stock purchases can come ahead of key information and potential gains.
While members of Congress likely don't have the same alleged insider information when it comes to cryptocurrency, trading activity in the sector warrants close monitoring, especially when it involves a meme cryptocurrency valued at around $225 million.
On Jan. 1, Collins disclosed that he purchased another $1,000 to $15,000 worth of Ski Mask Dog, adding to his previous disclosures in early December that he bought $2,000 to $30,000 worth of the meme coin.
The transaction, which can be viewed on <a href="https://www.benzinga.com/gov-trades">Benzinga's Government Trades page</a>, came on Dec. 3. That means that the same day that Collins' previous disclosed purchases began hitting the news, the Congressman was buying more of the coin.
Collins' latest trade was once again marked as unusual by several prominent social media accounts that track congressional trading activity.
<ul>
<li>"BREAKING: US politician Michael Collins has yet again bought crypto. He bought up to $15,000 of SKI MASK DOG, $SKI, crypto. Unusual," Unusual Whales <a href="https://x.com/unusual_whales/status/1874845104076390422">tweeted</a>.</li>
</ul>
<ul>
<li>"Congressman @RepMikeCollins just disclosed he bought more Ski Mask Dog on 12/3, the same day news of his first purchase broke and the coin rallied. So a Congressman single-handedly moved a market, then bought more, and disclosed it a month later," Congresstrading <a href="https://x.com/congresstrading/status/1874851774856884636">tweeted</a>.</li>
</ul>
Collins previously confirmed the purchase with Decrypt and also responded to a previous tweet from Unusual Whales with a meme of Pepe the Frog, a well-known image in the crypto community thanks to the meme cryptocurrency Pepe.
&#8220;I liked the coins, so I bought them,&#8221; Collins previously told Decrypt. &#8220;Washington and Wall Street have stigmatized emerging technology in the crypto ecosystem for far too long, and it&#8217;s about time that we start treating the industry with the respect it deserves.&#8221;
When asked about meme coins and if they need to be disclosed by members of Congress for trading activity, Collins said yes.
&#8220;Meme coins should certainly be treated as any other asset, digital or otherwise.&#8221;
Check This Out:
<ul>
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent123124">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Ski Mask Dog coin rallied in December after Collins first purchase was disclosed.
The coin hit an all-time high of $0.3639 on Dec. 5 after the Congressman's first purchase disclosure. The latest trade disclosure shows that Collins also bought more Ski Mask Dog coin on Dec. 3 ahead of the all-time highs.
Collins, who won re-election in the 2024 election, has previously disclosed buying and selling cryptocurrencies like Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), Aerodrome (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AERO</a>), Velodrome (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">VELO</a>) and The Graph (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">GRT</a>).
Collins' purchases of Ethereum have been larger in recent disclosures compared to the meme coin he recently bought. The congressman has also disclosed selling some of the cryptocurrencies in the past, which could make the recent meme coin buy one to watch in case he later shows he sold it after the recent gains.
Calls to ban members of Congress from buying stocks and options have grown, with President Joe Biden recently <a href="https://www.benzinga.com/24/12/42538504/biden-endorses-ban-of-congressional-stock-trading-nobody-in-the-congress-should-be-able-to-make-money-in-the-stock-market-while-in-office">endorsing a ban </a>on Congress trading.
When it comes to members of Congress buying and selling cryptocurrencies, there is less support and it is less mentioned in potential legislation.
&#8220;Nobody in the Congress should be able to make money in the stock market while they&#8217;re in the Congress,&#8221; Biden said, failing to mention cryptocurrency.
Members of Congress are currently allowed to buy and sell stocks, options, cryptocurrency and make other investments as long as they are disclosed in 45 days.
Collins' trade, which happened nearly 30 days ago and came as his past trade in the same coin may have led to the price soaring could spark interest in putting the same ban on cryptocurrency. With pro-crypto President-elect Donald Trump taking office later this month, more members of Congress could be looking to add cryptocurrency to their investment portfolios.
Ski Mask Dog, which began trading in 2024, is up 6% in the past day.
The meme cryptocurrency currently trades at $0.2246 at the time of writing Thursday, versus a one-month range of $0.1472 to $0.3639.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/01/36459015/10-best-stock-traders-in-congress-in-2023-spoiler-nancy-pelosi-is-back-on-the-list">10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Has Reentered The Chat)</a></li>
</ul>
Photo: SMRM1977 via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Politics

$AERO

$ETH

Golden Ratio Token - United States Dollar

$GRT

$VELO

Congressman Buys More Ski Mask Dog Coin: Will Meme Coin Hit New All-Time-Highs On Latest Disclosure?

&nbsp;
Michael Garcia, Chief Executive Officer of Algoma, commented, "Despite market headwinds, our results for the quarter demonstrated solid operational execution, particularly in our plate business where production continued on its upward trajectory. While macroeconomic uncertainties persist in the steel sector, we remain positioned to capitalize on improving fundamentals as conditions normalize."

Guidance

ASTL

Algoma Steel Expects December 2024 Quarter Total Steel Shipments Of 545K - 550K Tons;  Adjusted EBITDA Of C$(55)M - C$(65)M

Offerings

ARCC

Ares Capital Prices Public Offering Of $1B Of 5.800% Notes Due 2032

Ingersoll Rand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IR#NYSE">IR</a>) has outperformed the market over the past 5 years by 7.63% on an annualized basis producing an average annual return of 20.24%. Currently, Ingersoll Rand has a market capitalization of $36.48 billion. 
Buying $100 In IR: If an investor had bought $100 of IR stock 5 years ago, it would be worth $249.50 today based on a price of $90.52 for IR at the time of writing.
<h3>Ingersoll Rand's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735857014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Running a small, family-owned business is already a challenge, but having a corporate giant like Dunkin&#8217; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNKN#NASDAQ">DNKN</a>) set up shop right next door takes it to another level. That's the reality for one coffee drive-thru owner, who recently <a href="https://www.reddit.com/r/smallbusiness/comments/1hhes7t/i_own_a_small_family_owned_coffee_drive_thru/">shared</a> <a href="https://www.benzinga.com/real-estate/24/12/42727607/a-homebuyer-posts-were-not-falling-for-this-again-issuing-a-warning-to-fellow-house-hunters-on-local-boards">their frustration on social media and sought advice</a>. The post received significant attention, with over a thousand people offering support and suggestions.
&#8220;I&#8217;m honestly a little shook up and angry,&#8221; the post began. &#8220;Does anyone have any advice on how I should approach this or what I should be feeling?&#8221;
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
The responses poured in, ranging from strategic advice to words of encouragement.
<h2 class="wp-block-heading">Turn Competition Into Opportunity</h2>
Several commenters pointed out that Dunkin&#8217;s decision to open nearby could actually validate the location&#8217;s potential. One user noted, &#8220;They thought the area was good enough for their third location, so it must be great for <a href="https://www.benzinga.com/markets/commodities/24/04/38237838/bad-news-chocolate-and-coffee-lovers-prices-are-only-going-higher">coffee</a>. Use that to your advantage.&#8221; By drawing more coffee lovers to the area, Dunkin&#8217; might unintentionally bring new customers to the local drive-thru as well.
<h2 class="wp-block-heading">Double Down on Quality</h2>
The overwhelming consensus was to focus on what you do best. &#8220;Make better coffee, which you probably already do, understand what chains can&#8217;t offer and offer that. Cleaner, more comfortable eating area,&#8221; one commenter advised.&nbsp;
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
Others suggested emphasizing freshly made products, like pastries and specialty drinks, that big chains simply can&#8217;t replicate. &#8220;Dunkin&#8217; food and baked goods come packaged and frozen. A good local coffee joint that makes their food fresh every morning will get my business 100% of the time over a franchise like Dunkin, Starbucks or Tim Hortons,&#8221; said another.
<h2 class="wp-block-heading">Lean Into Local Roots</h2>
Being a family-owned business offers a competitive edge that corporations can't match. One advice was to highlight community involvement: &#8220;I would develop some strong talking points about how you&#8217;re local, family-owned, keep the money in the community, etc., where Dunkin&#8217; is a corporation that sends your community&#8217;s hard-earned money back to HQ.&#8221; Others recommended showcasing the personal side of the business, like the faces behind the counter or stories about how the shop started.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">Be Bold with Marketing</h2>
Several responses encouraged creative and even humorous marketing strategies. Ideas included putting up signs like &#8220;Support Local&#8221; or &#8220;Better Coffee, No Drive-Thru Lines.&#8221; One user suggested a tongue-in-cheek approach: &#8220;Put a sign out front: ‘Fresh 20oz coffee: $2.99 here. 20oz $4.99 coffee go there.'&#8221;
This small coffee drive-thru owner's story shows how hard it can be for small businesses to compete when big chains move in. But it also proves how creative and tough local business owners can be. As one commenter wisely said, &#8220;Don&#8217;t discount customer loyalty … a lot of folks don&#8217;t like big corporations coming in to try and hurt small, local businesses.&#8221;
Image via Flickr
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

DNKN

'Shook Up And Angry'—A Family-Owned Coffee Drive-Thru Owner Reacts As Dunkin' Opens Its 3rd Location Next Door

Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) has outperformed the market over the past 10 years by 4.74% on an annualized basis producing an average annual return of 15.94%. Currently, Insmed has a market capitalization of $12.51 billion. 
Buying $100 In INSM: If an investor had bought $100 of INSM stock 10 years ago, it would be worth $455.70 today based on a price of $69.95 for INSM at the time of writing.
<h3>Insmed's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735856108_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INSM

Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years

Las Vegas Sheriff Kevin McMahill announced Thursday that investigators now suspect the <a href="https://www.benzinga.com/general/entertainment/25/01/42757028/tesla-cybertruck-ignites-outside-trump-international-hotel-in-las-vegas">explosion of a Tesla Cybertruck</a> outside the Trump International Hotel on New Year&#8217;s Day was likely a suicide.
Speaking at a news conference Thursday, McMahill revealed that evidence suggests the driver died of a self-inflicted gunshot wound moments before the vehicle exploded. A firearm was found at the driver's feet inside the charred vehicle, <a href="https://www.washingtonpost.com/nation/2025/01/02/las-vegas-explosion-tesla-cybertruck-trump-hotel-colorado/">according to</a> the Washington Post.
Authorities are still working to confirm the driver's identity, as the body was burned beyond recognition. Preliminary evidence, they said, points to 37-year-old Matthew Livelsberger of Colorado Springs. 
Livelsberger was a Special Forces soldier on leave from a mission in Germany at the time of his death. He first enlisted in 2006 and had served multiple deployments, including to Afghanistan, the newspaper reported.
The FBI, as part of its Joint Terrorism Task Force, is investigating the case, which included searching a Colorado Springs residence on Thursday connected to the incident, though no further details were provided. "This activity is related to the explosion in Las Vegas," the FBI said in a statement.
Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk said on X that Tesla&#8217;s senior team is involved and has shared video footage from charging stations across the country.
Read Also: <a href="https://www.benzinga.com/news/25/01/42772041/fbi-confirms-lone-suspect-in-new-orleans-attack-vegas-probe-ongoing">FBI Says Suspect In New Orleans Attack Acted Alone; Vegas Cybertruck Explosion Suspect Identified</a>
<h2 class="wp-block-heading">Colleagues Shocked</h2>
Livelsberger's colleagues and former commanders expressed shock. Speaking on the condition of anonymity due to his work in the U.S. government, one soldier described Livelsberger as warm and caring, the Washington Post reported. 
Livelsberger held the rank of master sergeant and was assigned to the 10th Special Forces Group based in Colorado Springs.
Surveillance footage and Tesla data helped authorities track the Cybertruck's journey from Colorado to Las Vegas. The vehicle, rented in Colorado, arrived at the Trump Hotel around 7:30 a.m. Wednesday. It detonated an hour later. Video shared by authorities shows the truck, loaded with firework mortars and gas canisters, erupting in a fiery explosion near the hotel's entrance.
<h2 class="wp-block-heading">FBI Says No Link Between Las Vegas, NOLA Attack</h2>
Meanwhile, the FBI addressed concerns over potential links between this incident and a separate attack in New Orleans earlier this week. 
"There is no definitive link between the attack here in New Orleans and the one in Las Vegas," Christopher Raia, deputy assistant director of the FBI's counterterrorism division, said at a Thursday news conference on <a href="https://www.benzinga.com/media/25/01/42769136/turo-used-for-new-orleans-las-vegas-attacks-we-are-devastated-by-these-horrible-incidents">the New Orleans attack</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42772702/tesla-analyst-says-fsd-test-drive-shows-imperfections-not-ready-for-prime-time-yet">Tesla Analyst Says FSD Test Drive Shows Imperfections, &#8216;Not Ready For Prime Time Yet&#8217;</a></li>
</ul>
Photo: Shutterstock

TSLA

Tesla Cybertruck Explosion Outside Trump Las Vegas Hotel Was Likely Suicide, Authorities Say

Key Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analysts and influencers are out with their takes on the company's fourth-quarter delivery figures, which missed <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on">analyst consensus estimates.</a>
Here's a look at what they are saying and why 2025 could be a make-or-break year.
Daniel Ives on TSLA: Wedbush analyst <a href="https://www.benzinga.com/topic/dan-ives">Daniel Ives</a>, who is one of the biggest Tesla bulls on Wall Street, shared his take on Tesla's fourth-quarter delivery figures.
"TSLA announced its Q4 delivery numbers of 495.6k vehicles, below the Street's whisper number of ~500k. While knee jerk stock will be down, we view these as respectable numbers with all of our focus on the 2025 growth story and autonomous vision. Buyers today on any sell-off," Ives <a href="https://x.com/DivesTech/status/1874825698088722761">tweeted</a>.
Ives maintained an Outperform rating on Tesla with a $515 price target, as <a href="https://x.com/SawyerMerritt/status/1874825337894285750">shared </a>by Sawyer Merritt on X.
"We remain highly confident in Tesla's ability to accelerate delivery growth into FY25 with 20%-30% growth," Ives wrote in a new note.
Ross Gerber on TSLA: Tesla investor and Gerber Kawasaki Wealth and Investment Management CEO <a href="https://www.benzinga.com/topic/ross-gerber">Ross Gerber </a>took exception to the tweet from Ives above.
"Excuses. They used every discount they had to move vehicles and still couldn't. These Tesla numbers suck. No spin. Sorry," Gerber <a href="https://x.com/GerberKawasaki/status/1874829802097774881">tweeted </a>while sharing Ives' post.
Gerber went on to <a href="https://x.com/GerberKawasaki/status/1874830269154513235">criticize </a>Tesla's FSD v13 in another post and said the self-driving technology doesn't come close to Waymo's technology.
"No excuses FSD is not close."
Responding to a user who replied to Gerber's FSD post, the investment manager said, "close means nothing when it's people's life at risk."
"One can make excuses all day for Tesla but 2025 will be the prove it year… Can they grow sales? Can they grow profits ? Can they solve FSD? Can they make a new vehicle that is successful?&#8221; another Gerber <a href="https://x.com/GerberKawasaki/status/1874830913366048871">post </a>said.
Gerber <a href="https://www.benzinga.com/news/global/24/11/41999238/long-time-tesla-bull-rages-as-elon-musk-reportedly-backs-trumps-plan-to-ax-7-5k-ev-credit-insanity">recently took exception</a> to news that Tesla CEO Elon Musk backs the elimination of the $7,500 EV tax credit, calling it "insanity."
Read Also: <a href="https://www.benzinga.com/news/earnings/24/10/41501607/tesla-q3-earnings-highlights-eps-beat-revenue-miss-shares-climb-on-2025-timeline-for-lower-cost-evs">Tesla Q3 Earnings Highlights: EPS Beat, Revenue Miss, Shares Climb On 2025 Timeline For Lower-Cost EVs</a>
Gene Munster on TSLA: Deepwater Asset Management co-founder <a href="https://www.benzinga.com/topic/gene-munster">Gene Munster</a> said the "small" miss by Tesla Thursday doesn't matter to the long-term investment case for the stock.
"While Elon is focusing investors on autonomy, EV's still matter given those cars are the foundation of autonomy," Munster <a href="https://x.com/munster_gene/status/1874825401236934951">said</a>.
The investor said the deliveries figure missed the Street consensus by around 1%.
"All eyes now shift to Tesla earnings on Wednesday, Jan. 29. Besides the usual focus on margins, investors will be listening for updates to Musk delivery expectations for CY25."
Munster said one of the key questions is what Tesla and other EV companies' demand will look like outside of tax credits.
"I believe we'll be exiting the EV winter in 2025, and the segment will grow around 15% in 2025."
With Tesla shares falling Thursday, Munster suggested that part of the three-month rally in the stock&#8217;s price may have been driven by emotion. Similarly, he attributed Thursday&#8217;s decline to emotional reactions as well.
"While I'm bracing for a further pullback going into the January 29th earnings, I continue to believe that shares are undervalued over the long-term given Tesla's doing more in AI than any non-native AI company." 
The Delivery Figures: Tesla produced 459,445 vehicles and delivered 495,570 vehicles in the fourth quarter.
The delivery figure missed a street consensus estimate of 506,763 units, which Tesla shared <a href="https://www.benzinga.com/trading-ideas/previews/24/12/42745852/tesla-q4-delivery-preview-will-2024-stock-gains-hold-as-growth-slows">ahead of the report.</a>
Tesla had deliveries of 484,507 in last year's fourth quarter.
With the new report, Tesla's full-year delivery total is now 1.79 million units for 2024, down from a record 1.81 million in 2023. Tesla needed to report fourth-quarter deliveries of around 515,000 units to beat the 2023 full year total.
Thursday's report was the first time Tesla's annual delivery total has declined on a year-over-year basis.
Tesla previously said it expected to post growth in vehicle deliveries in 2024 and fell shy of that mark.
The comments from Ives, Gerber and Munster highlight the importance of 2025 in getting the company back on track with vehicle growth and other upcoming catalysts.
TSLA Price Action: Tesla stock was down 6% to $379.28 on Thursday, versus a 52-week trading range of $138.80 to $488.54. Tesla stock was up around 62% in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42772702/tesla-analyst-says-fsd-test-drive-shows-imperfections-not-ready-for-prime-time-yet">Tesla Analyst Says FSD Test Drive Shows Imperfections, &#8216;Not Ready For Prime Time Yet&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Reiteration

Movers

Tesla's First Sales Drop Splits Wall Street: '2025 Will Be The Prove It Year'

DCBO

Docebo Reports No Changes To Outlook As Previously Issued In Its Q3 Earnings Report On November 8, 2024

Mehta will continue to serve in his current role through February 28, 2025 to ensure an orderly transition as the board conducts a search to identify a successor that will include both internal and external candidates. Upon Mr. Mehta's departure, Brandon Farber, Senior Vice President – Finance will serve as Interim Chief Financial Officer.

Management

Docebo Says Sukaran Mehta Will Be Stepping Down From His Role As CFO; Brandon Farber, To Serve As Interim CFO

Throughout the last three months, 14 analysts have evaluated Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $38.21, along with a high estimate of $47.00 and a low estimate of $33.00. Observing a downward trend, the current average is 7.28% lower than the prior average price target of $41.21. 
<img src="https://www.benzinga.com/files/images/story/2025/1735855252_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Halliburton among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$33.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$43.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>James Rollyson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$37.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Kurt Hallead</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>David Anderson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$47.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$38.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$42.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$42.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Phillip Jungwirth</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$38.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Halliburton. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Halliburton compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Halliburton's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HAL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Halliburton analyst ratings.</a>
<h2>Discovering Halliburton: A Closer Look</h2>
Halliburton is North America's largest oilfield service company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. The firm's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been homed in over a century of operations.
<h3>Key Indicators: Halliburton's Financial Health</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Challenges: Halliburton's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -1.84%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: Halliburton's net margin is impressive, surpassing industry averages. With a net margin of 10.02%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Halliburton's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.63%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Halliburton's ROA excels beyond industry benchmarks, reaching 2.26%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.84.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Halliburton Stock: Analyst Perspectives (14 Ratings)

RBC Capital lowered the firm's price target on Hookipa Pharma (HOOK) to $48 from $50 and keeps an Outperform rating on the shares. Hookipa Pharma a...

Hookipa Pharma price target lowered to $48 from $50 at RBC Capital

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hookipa Pharma (HOOK – Research Report) and Cue Biop...

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Hookipa Pharma (HOOK – Research Report). The associated price target was...

Strategic Shift and Partnership Potential Drive Buy Rating for HOOKIPA Pharma

JMP Securities lowered the firm's price target on Hookipa Pharma (HOOK) to $7 from $24 and keeps an Outperform rating on the shares. Hookipa announ...

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities

In a regulatory filing on Wednesday, Hookipa Pharma (HOOK) announced that on November 18, the company approved a plan to continue to improve its co...

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program

Tracking Baker Brothers Portfolio - Q3 2024 Update

RBC Capital downgraded Hookipa Pharma (HOOK) to Sector Perform from Outperform with a price target of $2, down from $48. The company recently annou...

Hookipa Pharma downgraded to Sector Perform from Outperform at RBC Capital

RBC downgrades Hookipa, slashes price target

The boards of directors of Hookipa Pharma (HOOK) and Poolbeg Pharma announced that they have entered into non-binding discussions for an all-share ...

Hookipa Pharma to acquire Poolbeg Pharma

Check out this morning's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER – Topgolf Callaway (MODG) up 8% after Jefferies upgr...

Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint

ABCL

ACAD

ALGS

ALKS

ARCO

ARGNF

ARGX

AVTE

BABA

BCYC

BEIGF

BGNE

BMEA

CERS

DNLI

EWTX

GILD

GLUE

GOOG

GOOGL

IGMS

IMCR

IMTX

INCY

KALA

KNSA

KYMR

MDGL

MODG

NMRA

NRIX

RARE

REPL

RVMD

RYTM

SGMT

SIGA

SMMT

STOK

SYNA

TCRX

TRDA

TSVT

VTVT

Press Releases

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

HOOKIPA Pharma Announces Board of Directors Changes

Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

Health Care

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

Comments

HOOKIPA Pharma

HOOKIPA Pharma (HOOK) Forecast

HOOKIPA Pharma (NASDAQ:HOOK) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga